A Globally Accessible Solution for Rapid COVID-19 Testing

Share on facebook
Share on twitter
Share on linkedin
Share on reddit


Giving Compass’ Take:

• An article at Philanthropy News Digest reports on a partnership to make rapid COVID-19 testing affordable and accessible to low- and middle-income nations.

• How is rapid COVID-19 testing an essential ingredient in fending off the coronavirus? What are you doing to support sustainable, long-term solutions to provide rapid tests to countries with less access to such resources?

• Learn more about the full implications of rapid COVID-19 testing around the world.


The Access to COVID-19 Tools (ACT) Accelerator, a global collaboration focused on accelerating the production of and equitable access to COVID-19 tests, treatments, and vaccines, has announced an agreement to make affordable rapid COVID-19 antigen tests available in low- and middle-income countries (LMICs).

As part of the effort, the Bill & Melinda Gates Foundation has executed separate volume guarantee agreements with rapid diagnostic test producers Abbott and SD Biosensor to make a hundred and twenty million antigen rapid diagnostic tests available over six months to low- and middle-income countries at a maximum price of $5 per test. In addition, the Global Fund to Fight AIDS, Malaria…



Comments

Leave a Reply

Responses

Sign up for our Daily News Briefing

Get daily news delivered to your inbox. 

Build for us, by us...

Social Community

Breaking News

Business Directory

Connections

Grow

Forge Your Kingdom...

Community is Everything: Build a tribe of inspiring friends. Build a community, of like-minds, who will give you the strength to act on your ideas and inspire you to be the best version of you.

Community

Connect, Share, & Grow! Share your stories!

Mobile Friendly

Access the community from any device.

Buy Black

Thousands of minority-owned businesses at your fingertips.